West Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by Quest Partners LLC

Quest Partners LLC boosted its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 5,633.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 172 shares of the medical instruments supplier’s stock after buying an additional 169 shares during the period. Quest Partners LLC’s holdings in West Pharmaceutical Services were worth $57,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ballentine Partners LLC raised its holdings in shares of West Pharmaceutical Services by 4.7% in the second quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock valued at $244,000 after buying an additional 33 shares during the last quarter. Caprock Group LLC lifted its position in West Pharmaceutical Services by 6.6% during the 2nd quarter. Caprock Group LLC now owns 1,105 shares of the medical instruments supplier’s stock worth $364,000 after acquiring an additional 68 shares during the period. Acadian Asset Management LLC grew its stake in shares of West Pharmaceutical Services by 108.6% in the 2nd quarter. Acadian Asset Management LLC now owns 4,926 shares of the medical instruments supplier’s stock valued at $1,620,000 after purchasing an additional 2,565 shares during the last quarter. SRS Capital Advisors Inc. increased its holdings in shares of West Pharmaceutical Services by 11.3% in the second quarter. SRS Capital Advisors Inc. now owns 2,353 shares of the medical instruments supplier’s stock valued at $775,000 after purchasing an additional 238 shares during the period. Finally, Advisor OS LLC raised its stake in shares of West Pharmaceutical Services by 7.9% during the second quarter. Advisor OS LLC now owns 3,018 shares of the medical instruments supplier’s stock worth $994,000 after purchasing an additional 221 shares during the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Price Performance

Shares of NYSE WST opened at $309.20 on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.34 and a quick ratio of 1.68. The company has a market cap of $22.43 billion, a PE ratio of 40.93, a P/E/G ratio of 10.58 and a beta of 1.01. The stock has a fifty day moving average price of $304.36 and a 200 day moving average price of $338.16. West Pharmaceutical Services, Inc. has a 1-year low of $265.00 and a 1-year high of $413.70.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The firm had revenue of $702.10 million during the quarter, compared to analyst estimates of $729.36 million. During the same quarter last year, the business posted $2.11 EPS. The firm’s revenue was down 6.9% on a year-over-year basis. Sell-side analysts forecast that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current year.

Insider Buying and Selling at West Pharmaceutical Services

In other news, VP Charles Witherspoon sold 1,029 shares of the stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the transaction, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.53% of the stock is owned by corporate insiders.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.